Johns Hopkins Hospital Investigational Drug Services — Baltimore, Maryland

Johns Hopkins Hospital Investigational Drug Services is a clinical research site located in Baltimore, Maryland, United States 21287.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Johns Hopkins Hospital Investigational Drug Services has participated in 1 clinical trials.

Therapeutic areas: Bipolar Disorder.

Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Johns Hopkins Hospital Investigational Drug Services?

Johns Hopkins Hospital Investigational Drug Services has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Johns Hopkins Hospital Investigational Drug Services conducted?

Johns Hopkins Hospital Investigational Drug Services has 1 clinical trials on record. Their work covers Bipolar Disorder.

Is Johns Hopkins Hospital Investigational Drug Services accredited by Crixeo Health?

Johns Hopkins Hospital Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Johns Hopkins Hospital Investigational Drug Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.